BELLEVILLE, ON, Sept. 27 /CNW/ - Bioniche Life Sciences Inc. (TSX: BNC),
a research-based, technology-driven Canadian biopharmaceutical company, today
announced that its vaccine against E. coli O157:H7 in cattle has been
recognized internationally as the best new veterinary product for livestock.
The Company received the Animal Pharm industry excellence award at the Animal
Pharm Awards '07 dinner this week in London, UK. Animal Pharm is a worldwide
business-to-business news service for the animal health industries, published
by Informa Healthcare, part of the Informa Group. The Animal Pharm newsletter
has been published for more than 20 years and has more than 2,000 readers in
animal health companies and related businesses around the world
(www.animalpharmnews.com or www.animalpharmawards.com ).
